Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Inventory Average: 2021-2023

Historic Inventory Average for ADC Therapeutics (ADCT) over the last 2 years, with Sep 2023 value amounting to $21.1 million.

  • ADC Therapeutics' Inventory Average rose 38.69% to $21.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $21.1 million, marking a year-over-year increase of 38.69%. This contributed to the annual value of $11.6 million for FY2022, which is N/A change from last year.
  • Latest data reveals that ADC Therapeutics reported Inventory Average of $21.1 million as of Q3 2023, which was up 11.88% from $18.8 million recorded in Q2 2023.
  • ADC Therapeutics' Inventory Average's 5-year high stood at $21.1 million during Q3 2023, with a 5-year trough of $7,863 in Q3 2021.
  • Moreover, its 3-year median value for Inventory Average was $13.9 million (2022), whereas its average is $11.4 million.
  • Data for ADC Therapeutics' Inventory Average shows a peak YoY spiked of 193,178.65% (in 2022) over the last 5 years.
  • Over the past 3 years, ADC Therapeutics' Inventory Average (Quarterly) stood at $5.6 million in 2021, then spiked by 149.94% to $13.9 million in 2022, then surged by 38.69% to $21.1 million in 2023.
  • Its Inventory Average stands at $21.1 million for Q3 2023, versus $18.8 million for Q2 2023 and $15.2 million for Q1 2023.